<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37317323</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>20</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Total Osteopontin and Its Isoform OPN4 Are Differently Expressed in Respiratory Samples during Influenza A(H1N1)pdm09 Infection and Progression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1349</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms11051349</ELocationID><Abstract><AbstractText>Influenza A virus (IAV) infection affects the human respiratory tract, causing an acute and highly contagious disease. Individuals with comorbidities and in the extremes of age are classified as risk groups for serious clinical outcomes. However, part of the severe infections and fatalities are observed among young healthy individuals. Noteworthy, influenza infections lack specific prognostic biomarkers that would predict the disease severity. Osteopontin (OPN) has been proposed as a biomarker in a few human malignancies and its differential modulation has been observed during viral infections. However, OPN expression levels in the primary site of IAV infection have not been previously investigated. Therefore, we evaluated the transcriptional expression patterns of total OPN (<i>tOPN</i>) and its splicing isoforms (<i>OPNa, OPNb, OPNc, OPN4</i>, and <i>OPN5</i>) in 176 respiratory secretion samples collected from human influenza A(H1N1)pdm09 cases and a group of 65 IAV-negative controls. IAV samples were differentially classified according to their disease severity. <i>tOPN</i> was more frequently detected in IAV samples (34.1%) when compared with the negative controls (18.5%) (<i>p</i> &lt; 0.05), as well as in fatal (59.1%) versus non-fatal IAV samples (30.5%) (<i>p</i> &lt; 0.01). <i>OPN4</i> splice variant transcript was more prevalent in IAV cases (78.4%) than in the negative controls (66.1%) (<i>p</i> = 0.05) and in severe cases (85.7%) in relation to the non-severe ones (69.2%) (<i>p</i> &lt; 0.01). <i>OPN4</i> detection was also associated with severity symptoms such as dyspnea (<i>p</i> &lt; 0.05), respiratory failure (<i>p</i> &lt; 0.05), and oxygen saturation &lt; 95% (<i>p</i> &lt; 0.05). In addition, the <i>OPN4</i> expression level was increased in the fatal cases of respiratory samples. Our data indicated that <i>tOPN</i> and <i>OPN4</i> had a more pronounced expression pattern in IAV respiratory samples, pointing to the potential use of these molecules as biomarkers to evaluate disease outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Jéssica Santa Cruz de Carvalho</ForeName><Initials>JSCC</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz. Av. Leopoldo Bulhões, Manguinhos, 1480, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa</LastName><ForeName>Thiago das Chagas</ForeName><Initials>TDC</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz. Av. Leopoldo Bulhões, Manguinhos, 1480, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Maria de Lourdes de Aguiar</ForeName><Initials>MLA</Initials><Identifier Source="ORCID">0000-0002-2472-5263</Identifier><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz. Av. Leopoldo Bulhões, Manguinhos, 1480, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gimba</LastName><ForeName>Etel Rodrigues Pereira</ForeName><Initials>ERP</Initials><AffiliationInfo><Affiliation>Grupo de Hemato-Oncologia Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Praça da Cruz Vermelha, 23, andar 6, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de Pós-Graduação Stricto Sensu em Oncologia, Instituto Nacional de Câncer, Rua André Cavalcanti, 37, andar 3, Rio de Janeiro 20231-050, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de Pós-Graduação em Ciências Biomédicas, Fisiologia e Farmacologia, Instituto Biomédico, Av. Prof. Hernani Melo, 101, Niterói 24210-130, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ciências da Natureza, Universidade Federal Fluminense, Rua Recife 1-7, Bela Vista, Rio das Ostras 28880-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda Mendonça</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz. Av. Leopoldo Bulhões, Manguinhos, 1480, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matos</LastName><ForeName>Aline da Rocha</ForeName><Initials>ADR</Initials><Identifier Source="ORCID">0000-0001-7763-2127</Identifier><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz. Av. Leopoldo Bulhões, Manguinhos, 1480, Rio de Janeiro 20230-130, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>E26/201.360/2022</GrantID><Agency>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</Agency><Country /></Grant><Grant><GrantID>E26/210.100/2022</GrantID><Agency>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</Agency><Country /></Grant><Grant><GrantID>E-26/200.975/2022</GrantID><Agency>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</Agency><Country /></Grant><Grant><GrantID>312416/2021-0</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country /></Grant><Grant><GrantID>JSCCM</GrantID><Agency>Coordenação de Aperfeicoamento de Pessoal de Nível Superior</Agency><Country /></Grant><Grant><GrantID>TCS</GrantID><Agency>Coordenação de Aperfeicoamento de Pessoal de Nível Superior</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">expression</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">osteopontin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37317323</ArticleId><ArticleId IdType="pmc">PMC10224194</ArticleId><ArticleId IdType="doi">10.3390/microorganisms11051349</ArticleId><ArticleId IdType="pii">microorganisms11051349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Danielle Iuliano A., Roguski K.M., Chang H.H., Muscatello D.J., Palekar R., Tempia S., Cohen C., Michael Gran J., Schanzer D., Cowling B.J., et al. Estimates of global seasonal influenza-associated respiratory mortality: A modelling study HHS Public Access. Lancet. 2018;391:1285–1300. doi: 10.1016/S0140-6736(17)33293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)33293-2</ArticleId><ArticleId IdType="pmc">PMC5935243</ArticleId><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Global Influenza Strategy 2019–2030. World Health Organization; Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>World Helth Organization  Influenza (Seasonal)  [(accessed on 2 July 2019)].  Available online:  https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)</Citation></Reference><Reference><Citation>Whitaker J.A., von Itzstein M.S., Poland G.A. Strategies to maximize influenza vaccine impact in older adults. Vaccine. 2018;36:5940–5948. doi: 10.1016/j.vaccine.2018.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.08.040</ArticleId><ArticleId IdType="pubmed">30153995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Goicoechea S., Kumar S., Pearce C.M., Durvasula R., Kempaiah P., Rathi B. Poonam Oseltamivir analogs with potent anti-influenza virus activity. Drug Discov. Today. 2020;25:1389–1402. doi: 10.1016/j.drudis.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2020.06.004</ArticleId><ArticleId IdType="pubmed">32554062</ArticleId></ArticleIdList></Reference><Reference><Citation>Capão A., Aguiar-Oliveira M.L., Caetano B.C., Neves T.K., Resende P.C., Almeida W.A.F., Miranda M.D., Martins-Filho O.A.s., Brown D., Siqueira M.M., et al. Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil. Viruses. 2022;14:1692. doi: 10.3390/v14081692.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081692</ArticleId><ArticleId IdType="pmc">PMC9413331</ArticleId><ArticleId IdType="pubmed">36016313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa T.D.C., Martins J.S.C.C., Miranda M.D., Garcia C.C., Resende P.C., Santos C.A.D., Debur M.D.C., Rodrigues R.R., Cavalcanti A.C., Gregianini T.S., et al. Low prevalence of influenza A strains with resistance markers in Brazil during 2017–2019 seasons. Front. Public Health. 2022;10:944277. doi: 10.3389/fpubh.2022.944277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.944277</ArticleId><ArticleId IdType="pmc">PMC9516282</ArticleId><ArticleId IdType="pubmed">36187691</ArticleId></ArticleIdList></Reference><Reference><Citation>International Committee on Taxonomy of Viruses (ICTV)  [(accessed on 7 January 2020)].  Available online:  https://talk.ictvonline.org/taxonomy/</Citation></Reference><Reference><Citation>Dou D., Revol R., Östbye H., Wang H., Daniels R. Influenza A virus cell entry, replication, virion assembly and movement. Front. Immunol. 2018;9:1–17. doi: 10.3389/fimmu.2018.01581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01581</ArticleId><ArticleId IdType="pmc">PMC6062596</ArticleId><ArticleId IdType="pubmed">30079062</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E., Murakami S., Matsuzaki Y., Fujisaki S., Morita H., Nagata S., Katayama M., Mizuta K., Nishimura H., Watanabe S., et al. Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses. Viruses. 2023;15:244. doi: 10.3390/v15010244.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010244</ArticleId><ArticleId IdType="pmc">PMC9861540</ArticleId><ArticleId IdType="pubmed">36680284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.H., Hong K.J., Kim H., Nam J.H. Influenza vaccines: Past, present, and future. Rev. Med. Virol. 2022;32:e2243. doi: 10.1002/rmv.2243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2243</ArticleId><ArticleId IdType="pmc">PMC8209895</ArticleId><ArticleId IdType="pubmed">33949021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Liu Y., Lu A., Ni K., Xiang Z., Wen K., Tu W. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system. J. Autoimmun. 2017;77:1–10. doi: 10.1016/j.jaut.2016.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.10.006</ArticleId><ArticleId IdType="pubmed">28341037</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1)2009 Influenza Clinical Aspects of Pandemic 2009 Influenza. N. Engl. J. Med. 2010;18:1708–1719.</Citation><ArticleIdList><ArticleId IdType="pubmed">20445182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilyicheva T., Durymanov A., Susloparov I., Kolosova N., Goncharova N., Svyatchenko S., Petrova O., Bondar A., Mikheev V., Ryzhikov A. Fatal cases of seasonal influenza in Russia in 2015–2016. PLoS ONE. 2016;11:1–13. doi: 10.1371/journal.pone.0165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165332</ArticleId><ArticleId IdType="pmc">PMC5077104</ArticleId><ArticleId IdType="pubmed">27776172</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos A.R., Martins J.S., Maria de Lourdes A.O., Garcia C.C., Siqueira M.M. Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period. Infect. Genet. Evol. 2019;67:55–59. doi: 10.1016/j.meegid.2018.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2018.10.024</ArticleId><ArticleId IdType="pubmed">30389547</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins J.S.C., Oliveira M.L.A., Garcia C.C., Siqueira M.M., Matos A.R. Investigation of Human IFITM3 Polymorphisms rs34481144A and rs12252C and Risk for Influenza A(H1N1)pdm09 Severity in a Brazilian Cohort. Front. Cell. Infect. Microbiol. 2020;10:352. doi: 10.3389/fcimb.2020.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00352</ArticleId><ArticleId IdType="pmc">PMC7366732</ArticleId><ArticleId IdType="pubmed">32754450</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Goethem N., Danwang C., Bossuyt N., Van Oyen H., Roosens N.H.C., Robert A. A systematic review and meta-analysis of host genetic factors associated with influenza severity. BMC Genom. 2021;22:912. doi: 10.1186/s12864-021-08240-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-021-08240-7</ArticleId><ArticleId IdType="pmc">PMC8686082</ArticleId><ArticleId IdType="pubmed">34930124</ArticleId></ArticleIdList></Reference><Reference><Citation>Icer M.A., Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin. Biochem. 2018;59:17–24. doi: 10.1016/j.clinbiochem.2018.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2018.07.003</ArticleId><ArticleId IdType="pubmed">30003880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos A.C.S.D.F., Gomes A.V.P., Silva G.R., Emerenciano M., Ferreira L.B., Gimba E.R.P. The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles. Int. J. Mol. Sci. 2023;24:2429. doi: 10.3390/ijms24032942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032942</ArticleId><ArticleId IdType="pmc">PMC9917417</ArticleId><ArticleId IdType="pubmed">36769264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortell N., Flynn C., Conti B., Fox H.S., Marcondes M.C.G. Osteopontin Impacts West Nile virus Pathogenesis and Resistance by Regulating Inflammasome Components and Cell Death in the Central Nervous System at Early Time Points. Mediators Inflamm. 2017;2017:1–12. doi: 10.1155/2017/7582437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7582437</ArticleId><ArticleId IdType="pmc">PMC5547729</ArticleId><ArticleId IdType="pubmed">28811681</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampayo-Escobar V., Green R., Cheung M.B., Bedi R., Mohapatra S., Mohapatra S.S. Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection. PLoS ONE. 2018;13: e0192709. doi: 10.1371/journal.pone.0192709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192709</ArticleId><ArticleId IdType="pmc">PMC5909912</ArticleId><ArticleId IdType="pubmed">29677209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Li X., Wang Y., Li Y., Shi F., Diao H. Osteopontin aggravates acute lung injury in influenza virus infection by promoting macrophages necroptosis. Cell Death Discov. 2022;8:97. doi: 10.1038/s41420-022-00904-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-022-00904-x</ArticleId><ArticleId IdType="pmc">PMC8897470</ArticleId><ArticleId IdType="pubmed">35246529</ArticleId></ArticleIdList></Reference><Reference><Citation>Varım C., Demirci T., Cengiz H., Hacıbekiroğlu İ., Tuncer F.B., Çokluk E., Toptan H., Karabay O., Yıldırım İ. Relationship between serum osteopontin levels and the severity of COVID-19 infection. Wien. Klin. Wochenschr. 2021;133:298–302. doi: 10.1007/s00508-020-01789-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01789-5</ArticleId><ArticleId IdType="pmc">PMC7768087</ArticleId><ArticleId IdType="pubmed">33369698</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Altamirano M.M.B., Romano M., Legorreta-Herrera M., Sánchez-García F.J., Colston M.J. Gene expression in human macrophages infected with dengue virus serotype-2. Scand. J. Immunol. 2004;60:631–638. doi: 10.1111/j.0300-9475.2004.01519.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0300-9475.2004.01519.x</ArticleId><ArticleId IdType="pubmed">15584975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimba E.R.P., Brum M.C.M., De Moraes G.N. Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (Review) Int. J. Oncol. 2019;54:420–430. doi: 10.3892/ijo.2018.4656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2018.4656</ArticleId><ArticleId IdType="pubmed">30535434</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinman J.G., Wesson J.A., Hughes J. Osteopontin and Calcium Stone Formation. Nephron Physiol. 2004;98:p43–p47. doi: 10.1159/000080263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000080263</ArticleId><ArticleId IdType="pubmed">15499214</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen B., Petersen T.E., Sørensen E.S. Post-translational modification and proteolytic processing of urinary osteopontin. Biochem. J. 2008;411:53–61. doi: 10.1042/BJ20071021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20071021</ArticleId><ArticleId IdType="pubmed">18072945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos A.C.S.F., Blunck C.B., Emerenciano M., Gimba E.R.P. Osteopontin and their roles in hematological malignancies: Splice variants on the new avenues. Cancer Lett. 2017;408:138–143. doi: 10.1016/j.canlet.2017.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2017.08.022</ArticleId><ArticleId IdType="pubmed">28844708</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa T.D.C., Martins J.S.C.C., Miranda M.D., Garcia C.C., Resende P.C., Santos C.A., Debur M.D.C., Rodrigues R.R., Cavalcanti A.C., Gregianini T.S., et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Physiol. Behav. 2017;359:926–930. doi: 10.1126/science.aar3247.Detection.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar3247.Detection</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva G.R., Mattos D.S., Bastos A.C.F., Viana B.P.P.B., Brum M.C.M., Ferreira L.B., Gimba E.R.P. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines. Mol. Biol. Rep. 2020;47:8339–8345. doi: 10.1007/s11033-020-05867-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05867-9</ArticleId><ArticleId IdType="pubmed">33006711</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal J., Sarkar-Dutta M., McRae S., Ramachandran A., Kumar B., Waris G. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44. J. Virol. 2018;92:e02116-17. doi: 10.1128/JVI.02116-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02116-17</ArticleId><ArticleId IdType="pmc">PMC6002707</ArticleId><ArticleId IdType="pubmed">29669827</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H.B., Chen Q.Y., Wang X.Y., Zhang L.J., Hu L.P., Harrison T.J., Wang C., Fang Z.L. Infection with Hepatitis B Virus May Increase the Serum Concentrations of Osteopontin. Intervirology. 2021;64:126–134. doi: 10.1159/000513687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513687</ArticleId><ArticleId IdType="pmc">PMC8491474</ArticleId><ArticleId IdType="pubmed">33735879</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Wei Y., Chen J., Cui G. Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury. Jpn. J. Infect. Dis. 2015;68:467–473. doi: 10.7883/yoken.JJID.2014.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2014.467</ArticleId><ArticleId IdType="pubmed">25866117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X.M., Wang Y.F., Lyu Y., Zou Y., Wang X., Ruan S.M., Wu W.H., Liu H., Sun Y., Zhang R.L., et al. The effect of influenza A (H1N1) pdm09 virus infection on cytokine production and gene expression in BV2 microglial cells. Virus Res. 2022;312:198716. doi: 10.1016/j.virusres.2022.198716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2022.198716</ArticleId><ArticleId IdType="pubmed">35240224</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., McCaw J.M., Cao P. Modelling within-host macrophage dynamics in influenza virus infection. J. Theor. Biol. 2021;508:110492. doi: 10.1016/j.jtbi.2020.110492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2020.110492</ArticleId><ArticleId IdType="pubmed">32966828</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C., Xu W., Ai X., Zhu Y., Geng P., Niu Y., Zhu H., Zhou W., Huang H., Shi X. Autophagy and Exosome Coordinately Enhance Macrophage M1 Polarization and Recruitment in Influenza A Virus Infection. Front. Immunol. 2022;13:722053. doi: 10.3389/fimmu.2022.722053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.722053</ArticleId><ArticleId IdType="pmc">PMC8967985</ArticleId><ArticleId IdType="pubmed">35371077</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M., Kedzierska K., Subbarao K. Immune Responses to Avian Influenza Viruses. J. Immunol. 2019;202:382–391. doi: 10.4049/jimmunol.1801070.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801070</ArticleId><ArticleId IdType="pubmed">30617120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science. 2000;287:860–864. doi: 10.1126/science.287.5454.860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.287.5454.860</ArticleId><ArticleId IdType="pubmed">10657301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A.C., Sacramento C.Q., Pereira-dutra F.S., Silva P.P., Mattos M., de Freitas C.S., de Melo G.R., Macedo M.C., Azevedo-quintanilha I.G., Carlos A.S., et al. Macrophages Undergo Necroptosis during Severe Influenza A Infection and Contribute to Virus-Associated Cytokine Storm Short Title: Macrophages Necroptosis during Influenza A Infection. bioRxiv. 2022 doi: 10.1101/2022.04.20.488871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.20.488871</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi-zhi J., Guoa B., Thomas P.G. New fronts emerge in the influenza cytokine storm Xi-zhi. Physiol. Behav. 2017;39:541–550. doi: 10.1007/s00281-017-0636-y.New.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0636-y.New</ArticleId><ArticleId IdType="pmc">PMC5580809</ArticleId><ArticleId IdType="pubmed">28555383</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>